Pharmacokinetic (PK) and Tolerance Study of Natroba Topical Suspension in Pediatrics With an Active Head Lice Infestation
Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
A pharmacokinetic and tolerance study of Natroba (spinosad) Topical Suspension, 0.9% in
pediatric subjects 6 months to 4 years of age with an active head lice infestation.